W World Corp., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat a range of metabolic and nervous system disorders. The company focuses on the disorders of the brain-gut axis, pain/inflammation, and autoimmune, as well as gout disorders. Its lead compounds under clinically development include Levotofisopam, a non-sedating agent for the treatment of Gout; and Dextofisopam, a non-serotonergic agent, which has completed Phase IIa and Phase IIb clinical trials for the treatment of irritable bowel syndrome. The company was founded in 1990 and is headquartered in North Las Vegas, Nevada.

CEO

Employees

Country

United States

ISIN

US92942B1035

Listings

0 Comments

Share your thoughts

FAQ

What is W World stock price today?▼

The current price of WWHC is $0.02 USD — it has increased by +0% in the past 24 hours. Watch W World stock price performance more closely on the chart.

What is W World stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on OTCM exchange W World stocks are traded under the ticker WWHC.

What were W World earnings last quarter?▼

WWHC earnings for the last quarter are -0 USD per share, whereas the estimation was 0 USD resulting in a -∞% surprise. The estimated earnings for the next quarter are N/A USD per share.

How many employees does W World have?▼

As of July 17, 2026, the company has 2 employees.

In which sector is W World located?▼

W World operates in the Technology sector.

When did W World complete a stock split?▼

W World has not had any recent stock splits.